176 related articles for article (PubMed ID: 11891419)
1. Phenotypic variability in familial hypercholesterolaemia: an update.
Jansen AC; van Wissen S; Defesche JC; Kastelein JJ
Curr Opin Lipidol; 2002 Apr; 13(2):165-71. PubMed ID: 11891419
[TBL] [Abstract][Full Text] [Related]
2. Familial hypercholesterolaemia and LDL receptor mutations.
Soutar AK
J Intern Med; 1992 Jun; 231(6):633-41. PubMed ID: 1619386
[TBL] [Abstract][Full Text] [Related]
3. Severe familial hypercholesterolaemia: current and future management.
Farnier M; Bruckert E
Arch Cardiovasc Dis; 2012 Dec; 105(12):656-65. PubMed ID: 23199621
[TBL] [Abstract][Full Text] [Related]
4. Familial hypercholesterolaemia: mutations in the gene for the low-density-lipoprotein receptor.
Soutar AK
Mol Med Today; 1995 May; 1(2):90-7. PubMed ID: 17607901
[TBL] [Abstract][Full Text] [Related]
5. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.
Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G
Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356
[TBL] [Abstract][Full Text] [Related]
6. Clinical, diagnostic, and therapeutic aspects of familial hypercholesterolemia.
van Aalst-Cohen ES; Jansen AC; de Jongh S; de Sauvage Nolting PR; Kastelein JJ
Semin Vasc Med; 2004 Feb; 4(1):31-41. PubMed ID: 15199431
[TBL] [Abstract][Full Text] [Related]
7. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
8. Influence of genotype at the low density lipoprotein (LDL) receptor gene locus on the clinical phenotype and response to lipid-lowering drug therapy in heterozygous familial hypercholesterolaemia. The Familial Hypercholesterolaemia Regression Study Group.
Sun XM; Patel DD; Knight BL; Soutar AK
Atherosclerosis; 1998 Jan; 136(1):175-85. PubMed ID: 9544745
[TBL] [Abstract][Full Text] [Related]
9. [LDL receptor gene analysis and phenotypic variation of familial hypercholesterolemia].
Tada N
Nihon Rinsho; 1994 Dec; 52(12):3228-35. PubMed ID: 7853715
[TBL] [Abstract][Full Text] [Related]
10. Familial hypercholesterolaemia in Finland: common, rare and mild mutations of the LDL receptor and their clinical consequences. Finnish FH-group.
Vuorio AF; Aalto-Setälä K; Koivisto UM; Turtola H; Nissen H; Kovanen PT; Miettinen TA; Gylling H; Oksanen H; Kontula K;
Ann Med; 2001 Sep; 33(6):410-21. PubMed ID: 11585102
[TBL] [Abstract][Full Text] [Related]
11. [Low density lipoprotein receptor and hypercholesterolemia].
Bruckert E; Chapman J
Rev Prat; 1994 May; 44(10):1287-93. PubMed ID: 7939186
[TBL] [Abstract][Full Text] [Related]
12. Impact of a common mutation of the LDL receptor gene, in French-Canadian patients with familial hypercholesterolemia, on means, variances and correlations among traits of lipid metabolism.
Roy M; Sing CF; Betard C; Davignon J
Clin Genet; 1995 Feb; 47(2):59-67. PubMed ID: 7606845
[TBL] [Abstract][Full Text] [Related]
13. Homozygous familial hypercholesterolaemia: update on management.
France M
Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France.
Bruckert E; Kalmykova O; Bittar R; Carreau V; Béliard S; Saheb S; Rosenbaum D; Bonnefont-Rousselot D; Thomas D; Emery C; Khoshnood B; Carrié A
Atherosclerosis; 2017 Feb; 257():130-137. PubMed ID: 28131047
[TBL] [Abstract][Full Text] [Related]
15. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
[TBL] [Abstract][Full Text] [Related]
16. Heterozygous familial hypercholesterolaemia: the influence of the mutation type of the low-density-lipoprotein receptor gene and PvuII polymorphism of the normal allele on serum lipid levels and response to lovastatin treatment.
Vuorio AF; Ojala JP; Sarna S; Turtola H; Tikkanen MJ; Kontula K
J Intern Med; 1995 Jan; 237(1):43-8. PubMed ID: 7830029
[TBL] [Abstract][Full Text] [Related]
17. Genetic and metabolic factors predicting risk of cardiovascular disease in familial hypercholesterolemia.
Smilde TJ; van Wissen S; Wollersheim H; Kastelein JJ; Stalenhoef AF
Neth J Med; 2001 Oct; 59(4):184-95. PubMed ID: 11578794
[TBL] [Abstract][Full Text] [Related]
18. Influence of genetic variability in the nondeletion LDL-receptor allele on phenotypic variation in French-Canadian familial hypercholesterolemia heterozygotes sharing a 'null' LDL-receptor gene defect.
Bétard C; Kessling AM; Roy M; Davignon J
Atherosclerosis; 1996 Jan; 119(1):43-55. PubMed ID: 8929255
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.
Rabacchi C; Bigazzi F; Puntoni M; Sbrana F; Sampietro T; Tarugi P; Bertolini S; Calandra S
J Clin Lipidol; 2016; 10(4):944-952.e1. PubMed ID: 27578127
[TBL] [Abstract][Full Text] [Related]
20. [Application of gene technology in the diagnosis of familial hypercholesterolemia].
Leren TP; Bakken KS; Rødningen OK; Gundersen KE; Sundvold H; Berg K; Tonstad S; Ose L
Tidsskr Nor Laegeforen; 1997 Feb; 117(5):678-81. PubMed ID: 9102960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
